Technology offers

The OTT-SSPA offers the access service to all the technologies developed by the Andalusian Public Healthcare System, including patents, utility models, know-how and software. This space features all the technologies available in our Catalogue of Technology Offers We include over 50 new offers every year. If you cannot find what you are looking for, you can contact us here.

STEREOTACTIC DEVICE FOR THE TREATMENT OF BREAST CANCER WITH RADIOTHERAPY
A research group of the Andalusian Public Health System has developed a device for immobilization that improves breast cancer treatment with conventional radiotherapy and is suitable for SBRT and magnetic resonance.
NOVEL PHENYLPIPERAZINE DERIVATIVES FOR THE TREATMENT OF OPPORTUNISTIC VIRAL INFECTIONS AND AS ANTIBACTERIAL
A research group from the Andalusian Public Health System, in collaboration with the University of Seville, is developing potential antiviral and antibacterial agents with increased therapeutic activity against human adenovirus (HAdV), human cytomegalovirus (HCMV) and drug-resistant bacteria.
NEW THERAPY FOR THE PREVENTION AND TREATMENT OF DISEASES RELATED TO GLUCOSE METABOLISM
A research group from the Andalusian Public Health System, in collaboration with the University of Seville, has shown that N – procalcitonin (N-PCT) plays a role in glucose tolerance. Thus, N-PCT, N-PCT precursors, and/ or agonists are useful for the prevention and treatment of diseases related to glucose metabolism.
BIOMARKER FOR SUBARACHNOID HEMORRHAGE AND VASOSPASM
A research group of the Andalusian Public Health System, in collaboration with the University of Seville, has developed a method based on the use of RhoA as biomarker for the diagnosis, classification and/ or monitoring of Subarachnoid Hemorrhage as well as useful for the prediction or prognosis of suffering cerebral vasospasm after the same.
INFORMATION SYSTEM FOR THE INTEGRATED CARE OF PATIENTS WITH BREAST CANCER
A research group of the Andalusian Public Health System has developed a system that allows, through a structured document, the evolution of breast cancer patients by supporting integrated care of patients.
TELEDERMATOLOGY PLATFORM FOR REMOTE SCREENING OF SKIN CANCER (TELEDERMATOLOGY V2.0)
A research group of the Andalusian Public Health System, belonging to Virgen Macarena University Hospital (Seville), has developed and implemented a software platform to enhance communication systems between GP and dermatologists in skin cancer diagnostics.
MDI#PSORIASIS
A research group of the Andalusian Public Health System, belonging to Virgen Macarena University Hospital (Seville), has developed a decision-making algorithm that allows systematizing and homogenizing the decision-making in complex patients with psoriasis.
DEVICE FOR THE IMMOVILIZATION AND FASTENING OF BEDRIDDEN PATIENTS
A research group of the Andalusian Public Health System has developed a device designed to immobilize patients who remain long time confined to bed in a certain and variable position depending on prescription.
NS3 PROTEASE INHIBITORS OF THE HCV OBTAINED FROM EDIBLE FUNGUS A PARTIR DE HONGOS COMESTIBLES
A research group of the Andalusian Public Health System, in collaboration with the University of Seville and the CIBERehd, has identified and assayed an extract which inhibits the NS3 protease of the hepatitis C virus (HCV), useful for the treatment or prevention of infections caused by HCV.
DIAGNOSTIC KIT FOR SOFT TISSUE CANCER
A group of researchers from the Andalusian Public Health System, has developed a kit and method for detecting the rearrangement of STAT6 and/ or NAB2 genes useful for diagnosing cancer, specifically, soft tissue cancer.

Pages